Seed · Biotech · London, United Kingdom · Founded 2019 · 51–200 employees
Relation Therapeutics is a London-based biotechnology startup leveraging machine learning, high-resolution single-cell multi-omics, and human genetics to accelerate drug discovery. The company operates a Lab-in-the-Loop model that analyzes patient-derived tissue samples to identify and validate therapeutic targets across osteoporosis, dermatological conditions, and cardio-renal diseases. Its proprietary biological foundation model, MORGAN, powers the integration of AI with functional genomics directly on human cell systems. Relation signed a strategic collaboration agreement with Novartis worth up to $1.7 billion, which included $55 million in upfront payments, equity investment, and R&D funding. Additionally, the company expanded its commercial footprint by securing a $110 million AI research and dataset agreement with GSK.
No open roles listed right now.